Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Wealth building investment strategies can empower beginners to grow their finances. Explore effective approaches to start investing wisely.
21,485 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
ServiceNow has built a durable software platform with strong margins and steady growth. This article explains why the...
When Alphabet joins the Dow Jones Industrial Average, it signals a shift in how blue-chip names are chosen and weight...
Inflation remains a challenge, but certain businesses have pricing power that helps them weather higher costs. This a...
Billionaire investor Michael Burry has lodged a new tesla short bet, intensifying the debate over Tesla’s robotics pu...
Strategy disclosed a record Bitcoin liquidation of $216 million over the past week, signaling a dramatic shift toward...
The S&P 500 kicked off 2026 with a strong first half, delivering solid gains. This article breaks down what that coul...
A new player in the chip foundry race is signaling aggressive pricing. If a potential rival wants undercut, investors...
SpaceX and Amazon share a blueprint for infrastructure growth, but their earnings paths diverge, forcing investors to...
A widening trust gap is pushing American workers into siloed teams and news feeds. Executives are racing to rebuild d...
Oklo stock has faced big swings, but analysts see a potential upside. This guide breaks down what the projection to $...
OpenAI CEO Sam Altman says AI could someday run a major company better than its human leadership, a warning that coul...